Analysts’ Viewpoint on Hyaluronic Acid Products Market Scenario
Manufacturers in the hyaluronic acid products market are focusing on positive or limited negative-impact sectors such as orthopedic and ophthalmic end-use cases to keep the economies running during the ongoing COVID-19 pandemic. However, hyaluronic acid is associated with the possibility of redness and soreness when injected into the joint. Hence, manufacturers in the hyaluronic acid products market should increase awareness about the advantages of this compound, since this molecule only leads to rare cases of allergic reactions. With the rising prevalence of osteoarthritis, new uses of the molecule is being researched. Hyaluronic acid products are finding applications in reversing skin aging by modulating skin moisture.
The key revenue-generating applications of hyaluronic acid products are dermal fillers, osteoarthritis, ophthalmic surgery, and vesicoureteral reflux (VUR). Of these, the revenue of dermal fillers held the dominant share in the past few years, closely followed by the osteoarthritis and vesicoureteral reflux applications. Meanwhile, the revenue of vesicoureteral reflux is projected to rise at a promising rate over the forecast period. The spectacular pace of the growth of this application is primarily driven by the rising demand for minimally invasive surgical procedures. In addition, the burgeoning aging population in several developed and developing nations who need eye & orthopedic surgeries is further fueling the growth of the hyaluronic acid products market.
Manufacturers in the hyaluronic acid products market are conducting short-term, mid-term, and long-term planning to overcome interruptions across customer demand, supply of materials, and availability of logistics services. They are analyzing high-risk clients and customers where recovery of debt may be an issue amid the ongoing COVID-19 outbreak. The scarcity of raw materials is likely to be experienced due to production stoppages and labor shortages during the ongoing pandemic. Nevertheless, the reopening of country borders is helping resolve transport and logistic issues, owing to stringent regulations being followed during transport of raw materials for the hyaluronic acid products market.
The number of people ageing in North America and Europe is so high that in the year 2028, the number of people aged between 65 and above is estimated to be more than the number of children aged between five & below. Since the molecule of hyaluronic acid helps in drug delivery, wound repair, skin healing, etc., the geriatric population would be an important consumer base.
Additionally, hyaluronic acid is an important cancer biomarker, particularly of breast and prostate cancer. It is important to note here that one in nine men are at a risk of developing prostate cancer. Moreover, it is particularly true of older men who are at a higher risk. On the other hand, around 2.1 million women are impacted by breast cancer annually. This is likely to fuel the growth of the global hyaluronic acid products market.
Companies in the hyaluronic acid products market are boosting output capacities for single-injection, three-injection, and five-injection cycle products. Over the past few years, the revenue share of five-injection cycle is anticipated to lead among all product types. However, over the years, it has lost some share. The demand for hyaluronic acid molecule as the single-injection cycle treatment is preferred over five-injection cycles. This can be attributed to the growing demand for convenience among patients and the pressing need to avoid adverse effects that may arise after being exposed to the treatment. Shifting to a lower-duration treatment can help patients avoid symptoms such as itching, redness, and inflammation, which may be common after every dose. In the near future, the revenue share of single-injection cycle products will rise at a major CAGR over the forecast period.
Hyaluronic acid, one of the key components of the extracellular matrix (ECM), is a unique non-sulfated glycosaminoglycan that is well-distributed across different types of tissues such as connective tissues, epithelial, and neural tissues. The molecule performs a variety of physiological functions and has wide applications in areas of drug delivery, skin healing, and wound repair, particularly fetal wound healing. It is also shown to moderate the inflammation necessary for stabilizing the granulation tissue, thereby promoting healing.
The hyaluronic acid is being used as a biomarker for various cancer types, especially that of prostate and breast. In addition, they can help in monitoring the disease progression. Since the molecule promotes normal cushioning of tissues and lubricates the joints, it has wide applications in the orthopedic surgery. It also finds use in various eye surgeries, such as cataract removal and corneal transplantation.
|
Attribute |
Detail |
|
Market Size Value in 2020 |
US$ 8.5 Bn |
|
Market Forecast Value in 2028 |
US$ 15.2 Bn |
|
Growth Rate (CAGR) |
7.1% |
|
Forecast Period |
2021–2028 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Hyaluronic Acid Products Market – Segmentation
| Product |
|
| Application |
|
| Region |
|
Hyaluronic acid products market is expected to cross the value of US$ 15.2 Bn by the end of 2028
Hyaluronic acid products market is estimated to expand at a CAGR of 7.1% from 2021 to 2028
Hyaluronic acid products market is driven by rise in cases of bone and joint-related issues
The vesicoureteral reflux segment dominated the global hyaluronic acid products market and is projected to expand considerably during the forecast period
Key players in the global hyaluronic acid products market include Alcon, Inc., Anika Therapeutics, Inc., Allergan, Inc., F. Hoffmann-La Roche Ltd., Fidia Farmaceutici SpA, Ferring Pharmaceuticals, Inc., GALDERMA S.A., LifeCore Biomedical LLC
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hyaluronic Acid Products Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hyaluronic Acid Products Market Analysis and Forecast, 2018–2028
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Regulatory Scenario by Region/globally
5.3. Product/ Brand Analysis
5.4. Technological Advancements
5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Hyaluronic Acid Products Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2018–2028
6.3.1. Single-injection Cycle
6.3.2. Three-injection Cycle
6.3.3. Five-injection Cycle
6.4. Market Attractiveness, by Product
7. Global Hyaluronic Acid Products Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2018–2028
7.3.1. Osteoarthritis
7.3.2. Ophthalmic Surgery
7.3.3. Dermal Fillers
7.3.4. Vesicoureteral Reflux (VUR)
7.4. Market Attractiveness, by Application
8. Global Hyaluronic Acid Products Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region
9. North America Hyaluronic Acid Products Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2018–2028
9.2.1. Single-injection Cycle
9.2.2. Three-injection Cycle
9.2.3. Five-injection Cycle
9.3. Market Value Forecast, by Application, 2018–2028
9.3.1. Osteoarthritis
9.3.2. Ophthalmic Surgery
9.3.3. Dermal Fillers
9.3.4. Vesicoureteral Reflux (VUR)
9.4. Market Value Forecast, by Country, 2018–2028
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Application
9.5.3. By Country
10. Europe Hyaluronic Acid Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2018–2028
10.2.1. Single-injection Cycle
10.2.2. Three-injection Cycle
10.2.3. Five-injection Cycle
10.3. Market Value Forecast, by Application, 2018–2028
10.3.1. Osteoarthritis
10.3.2. Ophthalmic Surgery
10.3.3. Dermal Fillers
10.3.4. Vesicoureteral Reflux (VUR)
10.4. Market Value Forecast, by Country & Sub-region, 2018–2028
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Application
10.5.3. By Country & Sub-region
11. Asia Pacific Hyaluronic Acid Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2018–2028
11.2.1. Single-injection Cycle
11.2.2. Three-injection Cycle
11.2.3. Five-injection Cycle
11.3. Market Value Forecast, by Application, 2018–2028
11.3.1. Osteoarthritis
11.3.2. Ophthalmic Surgery
11.3.3. Dermal Fillers
11.3.4. Vesicoureteral Reflux (VUR)
11.4. Market Value Forecast, by Country & Sub-region, 2018–2028
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Application
11.5.3. By Country & Sub-region
12. Latin America Hyaluronic Acid Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2018–2028
12.2.1. Single-injection Cycle
12.2.2. Three-injection Cycle
12.2.3. Five-injection Cycle
12.3. Market Value Forecast, by Application, 2018–2028
12.3.1. Osteoarthritis
12.3.2. Ophthalmic Surgery
12.3.3. Dermal Fillers
12.3.4. Vesicoureteral Reflux (VUR)
12.4. Market Value Forecast, by Country & Sub-region, 2018–2028
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Application
12.5.3. By Country & Sub-region
13. Middle East & Africa Hyaluronic Acid Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2018–2028
13.2.1. Single-injection Cycle
13.2.2. Three-injection Cycle
13.2.3. Five-injection Cycle
13.3. Market Value Forecast, by Application, 2018–2028
13.3.1. Osteoarthritis
13.3.2. Ophthalmic Surgery
13.3.3. Dermal Fillers
13.3.4. Vesicoureteral Reflux (VUR)
13.4. Market Value Forecast, by Country & Sub-region, 2018–2028
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By Application
13.5.3. By Country & Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis By Company (2020)
14.3. Company Profiles
14.3.1. Alcon, Inc.
14.3.1.1. Company Details
14.3.1.2. Business Overview
14.3.1.3. Financial Overview
14.3.1.4. Strategic Overview
14.3.1.5. SWOT Analysis
14.3.2. Anika Therapeutics, Inc.
14.3.2.1. Company Details
14.3.2.2. Business Overview
14.3.2.3. Financial Overview
14.3.2.4. Strategic Overview
14.3.2.5. SWOT Analysis
14.3.3. Allergan, Inc.
14.3.3.1. Company Details
14.3.3.2. Business Overview
14.3.3.3. Financial Overview
14.3.3.4. Strategic Overview
14.3.3.5. SWOT Analysis
14.3.4. F. Hoffmann-La Roche Ltd.
14.3.4.1. Company Details
14.3.4.2. Business Overview
14.3.4.3. Financial Overview
14.3.4.4. Strategic Overview
14.3.4.5. SWOT Analysis
14.3.5. Fidia Farmaceutici SpA
14.3.5.1. Company Details
14.3.5.2. Business Overview
14.3.5.3. Financial Overview
14.3.5.4. Strategic Overview
14.3.5.5. SWOT Analysis
14.3.6. Ferring Pharmaceuticals, Inc.
14.3.6.1. Company Details
14.3.6.2. Business Overview
14.3.6.3. Financial Overview
14.3.6.4. Strategic Overview
14.3.6.5. SWOT Analysis
14.3.7. GALDERMA S.A.
14.3.7.1. Company Details
14.3.7.2. Business Overview
14.3.7.3. Financial Overview
14.3.7.4. Strategic Overview
14.3.7.5. SWOT Analysis
14.3.8. LifeCore Biomedical LLC
14.3.8.1. Company Details
14.3.8.2. Business Overview
14.3.8.3. Financial Overview
14.3.8.4. Strategic Overview
14.3.8.5. SWOT Analysis
14.3.9. Hyaltech Ltd.
14.3.9.1. Company Details
14.3.9.2. Business Overview
14.3.9.3. Financial Overview
14.3.9.4. Strategic Overview
14.3.9.5. SWOT Analysis
14.3.10. Meiji Seika Pharma Co., Ltd.
14.3.10.1. Company Details
14.3.10.2. Business Overview
14.3.10.3. Financial Overview
14.3.10.4. Strategic Overview
14.3.10.5. SWOT Analysis
14.3.11. Sanofi
14.3.11.1. Company Details
14.3.11.2. Business Overview
14.3.11.3. Financial Overview
14.3.11.4. Strategic Overview
14.3.11.5. SWOT Analysis
14.3.12. Merz Aesthetics, Inc.
14.3.12.1. Company Details
14.3.12.2. Business Overview
14.3.12.3. Financial Overview
14.3.12.4. Strategic Overview
14.3.12.5. SWOT Analysis
14.3.13. Salix Pharmaceuticals, Inc.
14.3.13.1. Company Details
14.3.13.2. Business Overview
14.3.13.3. Financial Overview
14.3.13.4. Strategic Overview
14.3.13.5. SWOT Analysis
14.3.14. Shanghai Jingfeng Pharmaceutical Co., Ltd.
14.3.14.1. Company Details
14.3.14.2. Business Overview
14.3.14.3. Financial Overview
14.3.14.4. Strategic Overview
14.3.14.5. SWOT Analysis
14.3.15. Seikagaku Corp.
14.3.15.1. Company Details
14.3.15.2. Business Overview
14.3.15.3. Financial Overview
14.3.15.4. Strategic Overview
14.3.15.5. SWOT Analysis
14.3.16. Smith & Nephew plc.
14.3.16.1. Company Details
14.3.16.2. Business Overview
14.3.16.3. Financial Overview
14.3.16.4. Strategic Overview
14.3.16.5. SWOT Analysis
14.3.17. Zimmer Holdings, Inc.
14.3.17.1. Company Details
14.3.17.2. Business Overview
14.3.17.3. Financial Overview
14.3.17.4. Strategic Overview
14.3.17.5. SWOT Analysis
14.3.18. TRB Chemedica Int. SA
14.3.18.1. Company Details
14.3.18.2. Business Overview
14.3.18.3. Financial Overview
14.3.18.4. Strategic Overview
14.3.18.5. SWOT Analysis
14.3.19. Other Prominent Players
14.3.19.1. Company Details
14.3.19.2. Business Overview
14.3.19.3. Financial Overview
14.3.19.4. Strategic Overview
14.3.19.5. SWOT Analysis
List of Tables
Table 1: Market Snapshot: Global Hyaluronic Acid Products Market (2020 & 2028)
Table 2: Global Hyaluronic Acid Products Market Revenue, by Products, 2017 –2028 (USD Million)
Table 3: Global Hyaluronic Acid Products Market Revenue, by Applications, 2017 –2028 (USD Million)
Table 4: Global Hyaluronic Acid Products Market Revenue, by Geography, 2017 –2028 (USD Million)
List of Figures
Figure 1: Hyaluronic Acid Products: Market Segmentation
Figure 2: Global Hyaluronic Acid Products Market, by Products, 2018 (USD Million)
Figure 3: Comparative Analysis: Global Hyaluronic Acid Products Market, by Geography, 2020 and 2028 (Value %)
Figure 4: Porter’s Five Forces Analysis: Global Hyaluronic Acid Products Market
Figure 5: Production Methods of Hyaluronic acid
Figure 6: Market Attractiveness Analysis: Global Hyaluronic Acid Products Market
Figure 7: Market Share Analysis: Hyaluronic Acid Products Market, 2020 (Value %)
Figure 8: Comparative Analysis: Types of Hyaluronic Acid Products
Figure 9: Global Single-Injection Products Market Revenue, 2018 – 2020 (USD Million)
Figure 10: Global Three-Injection Cycle Products Market Revenue, 2018 – 2020 (USD Million)
Figure 11: Global Five-Injection Cycle Products Market Revenue, 2018 – 2020 (USD Million)
Figure 12: Global Hyaluronic Acid Products Market Revenue, by Osteoarthritis Application, 2018 – 2020 (USD Million)
Figure 13: Global Hyaluronic Acid Products Market Revenue, by Ophthalmic Application, 2018 – 2020 (USD Million)
Figure 14: Global Hyaluronic Acid Products Market Revenue, by Dermal Filler Application, 2018 – 2020 (USD Million)
Figure 15: Global Hyaluronic Acid Products Market Revenue, by Vesicoureteral Reflux Application, 2018 – 2020 (USD Million)
Figure 16: North America Hyaluronic Acid Products Market Revenue, 2018 – 2020 (USD Million)
Figure 17: Europe Hyaluronic Acid Products Market Revenue, 2018 – 2020 (USD Million)
Figure 18: Asia-Pacific Hyaluronic Acid Products Market Revenue, 2018 – 2020 (USD Million)
Figure 19: Latin America Hyaluronic Acid Products Market Revenue, 2018 – 2020 (USD Million)
Figure 20: Middle East & Africa Hyaluronic Acid Products Market Revenue, 2018 – 2020 (USD Million)
Figure 21: Alcon, Inc., Annual Revenue: 2010 – 2018 (USD Million)
Figure 22: Allergan, Inc., Annual Sales Revenue: 2010 – 2018 (USD Million)
Figure 23: Anika Therapeutics, Inc., Annual Revenue: 2010– 2018 (USD Million)
Figure 24: F. Hoffmann-La Roche Ltd., Annual Revenue: 2010 – 2018 (USD Million)
Figure 25: Galderma S.A., Annual Revenue: 2010 – 2018 (USD Million)
Figure 26: Lifecore Biomedical LLC. Annual Revenue: 2010– 2018 (USD Million)
Figure 27: Meiji Seika Pharma Co., Ltd., Annual Revenue: 2010 – 2018 (USD Million)
Figure 28: Merz Aesthetics Inc., Annual revenue: 2010 – 2018 (USD Million)
Figure 29: Sanofi, Annual Revenue: 2010 – 2018 (USD Million)
Figure 30: Salix Pharmaceuticals, Inc., Annual Revenue: 2010 - 2018 (USD Million)
Figure 31: Seikagaku Corporation, Annual Revenue: 2010 – 2018 (USD Million)
Figure 32: Smith & Nephew PLC, Annual Revenue: 2010 – 2018 (USD Million)
Figure 33: Zimmer Holdings. Inc., Annual Revenue: 2010 – 2018 (USD Million)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Hyaluronic Acid Products Market
